Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 7/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | PTGIR | P43119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18467727 | 0.89 | ALDH1A1 (0.38) | ALDH1A1THRBTSHRACHEEPHX1 | |
| SCHEMBL18672218 | 0.88 | ALDH1A1 (0.37) | ALDH1A1THRBTSHRACHEEPHX1 | |
| SCHEMBL17875652 | 0.87 | THRB (0.38) | ALDH1A1THRBTSHR | |
| SCHEMBL21547336 | 0.84 | ACHE (0.44) | ALDH1A1THRBTSHRACHE | |
| SCHEMBL17875657 | 0.83 | ALDH1A1 (0.33) | ALDH1A1THRBTSHR | |
| SCHEMBL154983 | 0.82 | ALDH1A1 (0.53) | ALDH1A1THRBTSHR | |
| SCHEMBL17875635 | 0.82 | TSHR (0.33) | ALDH1A1THRBTSHR | |
| SCHEMBL18467741 | 0.80 | TSHR (0.41) | ALDH1A1THRBTSHRCHRM2CHRM1 | |
| SCHEMBL13966739 | 0.79 | ALDH1A1 (0.46) | ALDH1A1THRBTSHRCHRNB2CHRNB4 | |
| SCHEMBL13976142 | 0.79 | ALDH1A1 (0.46) | ALDH1A1THRBTSHRPTGIR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9604918-B2 | Carboxylic acid ester/carbamate compound with polymerizable functional group and fluorine atom group, and manufacturing method therefor | UNIMATEC CO., LTD. (JP) | 2017-03-28 | — | — | US | disclosed |
| US-20160185714-A1 | CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR | UNIMATEC CO., LTD. (JP) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185714-A1 | CARBOXYLIC ACID ESTER/CARBAMATE COMPOUND WITH POLYMERIZABLE FUNCTIONAL GROUP AND FLUORINE ATOM GROUP, AND MANUFACTURING METHOD THEREFOR | FFAR2, DECR2, FFAR1 | ALDH1A1 557/4885THRB 1091/4885TSHR 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.